Patents

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2011/0177138 ALCOHOL-RESISTANT SUSTAINED-RELEASE ORAL PHARMACEUTICAL FORM BASED ON MICROGRANULES
Oral pharmaceutical form containing microgranules for the sustained release of at least one active principle, including a neutral carrier that is insoluble in...
2011/0177137 NOVEL DOSAGE FORM OF PALIPERIDONE AND PROCESS FOR PREPARING THE SAME
The present invention relates to an extended release composition of paliperidone for oral administration comprising paliperidone and at least one matrixing...
2011/0177136 METHOD AND PRODUCT
The present invention provides a method of producing a co-crystal, the method comprising the steps of providing a first substance and a second substance,...
2011/0177135 METHODS OF TREATING CARTILAGE DEFECTS
The present invention provides methods of repairing and regenerating cartilage tissue by administering into the cartilage or the area surrounding the cartilage...
2011/0177134 Viable Tissue Repair Implants and Methods of Use
Biocompatible tissue implants are provided for repairing a tissue injury or defect. The tissue implants comprise a biological tissue slice that serves as a...
2011/0177133 USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION
The invention pertains to the use of opioid antagonists for the treatment of urinary retention.
2011/0177132 Compositions and Methods for Generating Musculoskeletal Tissue
The present disclosure provides compositions comprising musculoskeletal cells and mesenchymal stem cells in discrete regions. The present disclosure provides...
2011/0177131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSION
The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene...
2011/0177130 METHODS FOR PREPARATION OF LIPID-ENCAPSULATED THERAPEUTIC AGENTS
Fully lipid-encapsulated therapeutic agent particles of a charged therapeutic agent are prepared by combining a lipid composition containing preformed lipid...
2011/0177129 Methods and Compositions Using Peroxiredoxin 1 (PRX1) as an Adjuvant
Provided are compositions and methods for stimulating immune responses against antigens. The compositions contain an antigen to which a stimulated immune...
2011/0177128 IMMUNOTHERAPY COMPOSITIONS AND METHODS OF TREATMENT
Provided are compositions that include one or more natural, recombinant and/or modified allergens; with a pharmaceutically acceptable non-aqueous solvent to...
2011/0177127 Brucella Abortus Proteins and Methods of Use Thereof
Compositions and methods for the diagnosis and prevention of B. abortus infection are provided.
2011/0177126 BACTERIA AND DERIVED PRODUCTS TO REINFORCE THE BODY DEFENCES AND TO REDUCE THE RISK OF DISEASE
This invention relates to a new strain of the genus Bifidobacterium and the components of its supernatants of cultivation in the form of various preparations...
2011/0177125 HSV-1 AND HSV-2 VACCINES AND METHODS OF USE THEREOF
This invention provides methods of vaccinating a subject against a Herpes Simplex Virus (HSV) infection and disorders and symptoms associated with same, and...
2011/0177124 CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION
The invention is related to polynucleotide-based cytomegalovirus vaccines. In particular, the invention is plasmids operably encoding HCMV antigens, in which...
2011/0177123 Recombinant Live Attenuated Foot-and-Mouth Disease (FMD) Vaccine Containing Mutations in the L Protein Coding...
Previously we have identified a conserved domain (SAP, for SAF-A/B, Acinus, and PIAS) in the foot-and-mouth disease virus (FMDV) leader (L) protein coding...
2011/0177122 DNA PRIME/ACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS
The present invention relates to a combination of a priming composition and a boosting composition to prime and boost an immune response in a subject whereby...
2011/0177121 Immunogenic Influenza Composition
Novel compositions useful as influenza immunogens are provided. The compositions enable a host response to immunogen sites normally not recognized by a host.
2011/0177120 MYCOBACTERIUM TUBERCULOSIS VACCINE
The present invention relates to the use of live mycobacterium of the M. tuberculosis complex for preparing a medicament, wherein the function of the zmp1-gene...
2011/0177119 STABLE, DRIED ROTAVIRUS VACCINE, COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF
The present invention provides novel lyophilized rotavirus vaccine formulations and methods of their preparation. The formulations include vaccine stabilizers,...
2011/0177118 Non-Simian Cells for Growth of Porcine Reproductive and Respiratory Syndrome (PRRS) Virus
Disclosed are compositions and methods relating to growth of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) using non-simian cells. In a particular...
2011/0177117 CHIMERIC RESPIRATORY SYNCYTIAL VIRUS POLYPEPTIDE ANTIGENS
Chimeric respiratory syncytial virus (RSV) polypeptide antigens are provided. The disclosed polypeptides include a first amino acid sequence comprising an F2...
2011/0177116 Methods of Immunizing Pregnant Heifers at Three Months of Gestation
The present invention discloses methods for protecting newborn calves against neonatal diarrhea by vaccinating pregnant cows and/or pregnant heifers, while...
2011/0177115 VACCINATION REGIMEN
The present invention provides a method of raising an immune response in a subject against an antigen. The method involves the steps of a) administering to the...
2011/0177114 IMMEDIATE PROTECTION AGAINST PATHOGENS VIA MVA
The invention relates to the methods and kits comprising modified vaccinia virus Ankara (MVA) to provide immediate protection against pathogens. MVA can be...
2011/0177113 USE OF ANTRODIA CAMPHORATA FOR TREATING DISEASES
The present invention relates to the use of antrodia camphorata in the treatment of skin conditions, allergic rhinitis, diabetes mellitus and its complications,...
2011/0177112 MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMA VIRUS INFECTION
Embodiments of the invention are directed to methods and compositions for generating an antibody response against HPV epitopes using multi-component vaccines....
2011/0177111 PROTECTIVE VACCINE AGAINST STAPHYLOCOCCUS AUREUS BIOFILMS COMPRISING CELL WALL-ASSOCIATED IMMUNOGENS
Vaccine formulations effective against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) are disclosed, as well as methods of...
2011/0177110 COMPOSITIONS COMPRISING CATIONIC MICROPARTICLES AND HCV E1E2 DNA AND METHODS OF USE THEREOF
Immunogenic HCV E1E2.sub.809 DNA compositions and methods of using the same are described. The compositions comprise HCV E1E2.sub.809 DNA adsorbed to cationic...
2011/0177109 ANTIGENIC TAU PEPTIDES AND USES THEREOF
The present disclosure relates to novel immunogens and compositions comprising an antigenic tau peptide, preferably linked to an immunogenic carrier for use in...
2011/0177108 LIPID COMPOUNDS FOR SUPRESSION OF TUMORIGENESIS
The present invention provides compounds, or pharmaceutically acceptable salts or analogs thereof, which exhibit anti-tumor activity. The present invention also...
2011/0177107 PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS
Methods of predicting the immunogenicity of a therapeutic protein in a subject are provided and the use of this method in selecting a protein for replacement...
2011/0177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders
The subject invention provides novel and advantageous materials and methods for treating neuroinflammation, neurodegenerative disease, and cerebrovascular...
2011/0177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their...
The present invention concerns the discovery of new selective inhibitors of ubiquitin specific proteases, their process of preparation and their therapeutic use.
2011/0177104 METHOD FOR SELECTIVE DEPLETION OF CD137 POSITIVE CELLS USING ANTI-CD137 ANTIBODY-TOXIN COMPLEX
The present invention relates to method for depletion of CD137 positive cells using an anti-CD137 antibody-toxin complex, and more particularly, to a method for...
2011/0177103 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those...
2011/0177102 TARGETED DOUBLE STRANDED RNA MEDIATED CELL KILLING
A method of killing a specific target cell/tissue is disclosed. The method comprises exposing the specific target cell/tissue to a composition-of-matter which...
2011/0177101 TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY
Provided is a method of treating cancer in a subject by inhibiting expression of PAX2. An example of a cancer treated by the present method is prostate cancer....
2011/0177100 TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY
Provided is a method of treating cancer in a subject by inhibiting expression of PAX2. An example of a cancer treated by the present method is prostate cancer....
2011/0177099 GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE
Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods...
2011/0177098 TM4SF4 AND MODULATORS THEREOF AND METHODS FOR THEIR USE
The present invention relates to methods for modulating a .beta.-cell population using a TM4SF4 modulator or a modulator of a TM4SF4 homolog. More particularly,...
2011/0177097 METHODS FOR MODULATING EXPRESSION OF CREB
Methods are provided for modulating CREB by administering a CREB-specific modulator. Also provided are methods for treating cardiovascular and metabolic...
2011/0177096 USE OF GPR151 MODULATORS FOR THE TREATMENT OF PAIN
The present invention relates to nucleic acid arrays used to detect genes which are up or down regulated following a pain stimulus in a mammal. It further...
2011/0177095 ANTI-HER2 ANTIBODIES AND THEIR USES
The present disclosure relates to antibodies directed to HER2 and uses of such antibodies, for example to treat diseases associated with the activity and/or...
2011/0177094 IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE
The present invention provides methods for providing a prognosis of treatment of diseases associated with inflammatory disease of the brain, including MS, e.g.,...
2011/0177093 USE OF BCMA AS AN IMMUNOREGULATORY AGENT
The disclosure relates to B-cell maturation antigen (BCMA), a receptor for APRIL and BAFF, and its use as an immunoregulatory agent in treatment of...
2011/0177092 INDIVIDUAL 5-FLUOROURACILE DOSE OPTIMIZATION IN FOLFIRI TREATMENT
The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively...
2011/0177091 Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1)
Provided is a method for inhibiting angiogenesis in a tumor. The method involves administering to an individual who has a tumor a composition that contains an...
2011/0177090 Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies
The present invention provides compositions and methods for the specific and sensitive detection and characterization of anti-carbohydrate antibodies against...
2011/0177089 APOPTOSIS INDUCER
Provided is an agent which is useful for diagnosis, prevention, and treatment of various diseases induced by an oxidative stress. Disclosed are secreted eIF5A...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 | Next →